Pica code IPD-2026-040 Breast cancer in the era of antibodies drug-conjugates: markers of efficacy and resistance.

Scientific-Disciplinary Group

06/MEDS-09 - Blood Diseases, Oncology And Rheumatology

Description

The winner will be involved in the study and correlation of prognostic and predictive factors, both well-established and newly identified, aimed at the personalization of treatment strategies for patients with metastatic breast cancer, with particular focus on those treated with antibody–drug conjugates. The research activity will be based on the analysis of real-world data, integrated with biomolecular approaches (immunohistochemistry, next-generation sequencing, etc.), and will extend to the exploration of emerging research areas, such as the study of extracellular vesicles and other potential innovative biomarkers, within a translational research framework.

Compensation

28,456 Euro

Job posting website

https://titulus-unimore.cineca.it/albo/

Number of positions

1

Maximum duration

36.0

Funding body

UNIMORE

How to apply

Other

Selection process